logo-loader
AIM:CLBX

CelLBxHealth PLC

Receive alerts
Market:
AIM
Price
0.64 GBX
Day Change
6.50%
Market Cap:
£7.26 m
52 weeks high
2.80
52 weeks low
0.53

In brief

CelLBxHealth plc is a CTC intelligence company specializing in innovative circulating tumor cell (CTC) solutions for use in research, drug development and clinical oncology.

The company's patent-protected Parsortix® platform harvests CTCs from blood and can be integrated with existing laboratory instruments for comprehensive downstream analysis - including whole-cell imaging, proteomic profiling and full genomic workflows.

Snapshot

  • CelLBxHealth lands contract with Swiss biotech for clinical study
  • ANGLE's full potential yet to be recognised by the market, says research house
  • CelLBxHealth moves from cutting to converting
  • ANGLE announces second assay with AstraZeneca as it deepens relationship with pharma giant